Ray Kall
Senior Director, Managed Markets East at BridgeBio | United States
Ray Kall’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Senior Director, Managed Markets East at BridgeBio in November 2023 - Present
Executive Director- National, Federal and Regional Accounts at AVEO Oncology in June 2020 - November 2023
National Account Director- Oncology/Transplant at Sanofi Genzyme in April 2019 - June 2020
Regional Account Director- Sanofi-Genzyme at Sanofi Genzyme in October 2017 - April 2019
National Account Director at Egalet Corporation in March 2017 - October 2017
Director- Market Access at Novo Nordisk in August 2015 - December 2016
Executive Account Manager at Novo Nordisk in January 2010 - July 2015
Global Marketing Director- Sales Excellence at Novo Nordisk in July 2008 - January 2010
Project Director for Global Selling and Training at Novo Nordisk in May 2007 - July 2008
Regional Sales Director at Novo Nordisk in March 2003 - May 2007
District Manager at Novo Nordisk in May 2001 - May 2003
Bethpage high school, general, January 1978 to January 1982
The University of Georgia, Bachelor of Science (BS), January 1984 to January 1988
AVEO is a commercial-stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer. AVEO currently markets FOTIVDA® (tivozanib) in the U.S. for the treatment of adult patients with relapsed or refractory renal cell carcinoma (RCC) following two or more prior systemic therapies. AVEO continues to develop FOTIVDA in immuno-oncology combinations in RCC and other indications, and has other investigational programs in clinical development. AVEO is committed to creating an environment of diversity, equity and inclusion to diversify representation within the Company.
Discover more about BridgeBio
Senior Vice President, Development Operations
Senior Vice President, Development Operations at Sling Therapeutics
(March 2025 – Present)
Director, Pharmacovigilance Systems and Data Management at AVEO Oncology
Director, Pharmacovigilance Systems and Data Management at AVEO Oncology
(August 2023 – Present)
Vice President, IT AVEO Oncology
Vice President, Information Technology at AVEO Oncology
(July 2023 – Present)
Oncology Account Manager at AVEO Oncology
Oncology Account Manager at AVEO Oncology
(February 2021 – Present)
Novartis Oncology Specialist- 7x President’s Club Winner - Launch - Start ups
Oncology Specialist, Radioligand Therapy at Novartis Oncology
(April 2024 – Present)
Medical Affairs Leader
Executive Director, Head of Global Field Medical Affairs at Viridian Therapeutics, Inc.
(February 2025 – Present)
What is Ray Kall email address?
Email Ray Kall at [email protected] and [email protected]. This email is the most updated Ray Kall's email found in 2026.
What is Ray Kall phone number?
Ray Kall phone number is 980-216-9485.
How to contact Ray Kall?
To contact Ray Kall send an email to [email protected] or [email protected]. If you want to call Ray Kall try calling on 980-216-9485.
What company does Ray Kall work for?
Ray Kall works for BridgeBio.
What is Ray Kall's role at BridgeBio?
Ray Kall is Senior Director, Managed Markets East
What industry does Ray Kall work in?
Ray Kall works in the Pharmaceuticals industry.
